Direct-acting oral anticoagulants (DOACs): reminder of bleeding risk, including availability of reversal agents

2020-06-29T15:20:07+01:00

…Specific reversal agents are available for dabigatran (Praxbind▼, idarucizumab), and apixaban and rivaroxaban (Ondexxya▼, andexanet alfa).…